Medical Device News Magazine

Neoss ® Group Receives EU MDR Certifications for Implants and Abutments

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. This certification adds to the previous MDR certification of Neoss’ Quality Management System and Class I Reusable instruments that was granted in 2022. This signifies that Neoss Group’s Quality Management System and its implants and abutments meet the requirements of the new MDR implemented by the European Union.

“MDR is one of the most thorough medical device regulations in the world. It ensures that medical devices meet the highest standards. The certification shows that we are in the forefront of implant solutions and that we provide best in class quality and care to our customers and their patients.” Dr. Robert Gottlander, President and CEO of the Neoss Group.

This once again demonstrates that Neoss Group is at the forefront of their commitment to ensuring that their products adhere to the highest standards for the benefit of their customers and their patients. They are also one of the first companies in the dental device field to achieve MDR certification for their products.

“The MDR certification gives Neoss the freedom to continue innovating intelligent solutions that benefit our customer and their patients. The MDR certification also shows that Neoss products are backed with clinical evidence of the highest standard and ensures that the products are continuously monitored in post-market studies.” Mr. Fredrik Engman, CTO and co-founder of Neoss.”

The new EU Medical Devices Regulation 2017/745 (MDR) replaces the former European Medical Device Directive 93/42/EEC (MDD), and brings EU legislation into line with technical advances, changes in medical science and progress in law-making. The new MDR regulation creates a robust, transparent, and sustainable regulatory framework, improving clinical safety and creating fair market access for manufacturers and healthcare professionals. The new MDR regulation contains a series of important improvements including establishing a comprehensive and accessible EU database on medical devices with a device traceability system based on a unique device identification.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”